Delivery Order SPE2DR25D2014-SPE2DR26FZ94S
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $23,573.76 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3,...
- The Defense Logistics Agency awarded a $5,814.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 2, 2025, with completion scheduled for December 3, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.73 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,769.00 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $3,725.80. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract is set to be completed by December 5, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,814.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on December 5, 2025, with completion expected by December 8, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $2,021.80. This competitive award represents a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, indicating it was awarded through open competition. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $3,856.80. This is a firm fixed price delivery order with no set-aside designation, requiring completion by December 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,685.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on November 12, 2025, with completion expected by November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 3 mg/0.5 ml pens valued at $4,224.50 with a completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract vehicle. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ94SDelivery Order
This delivery order, awarded to AmerisourceBergen Drug Corp on December 11, 2025, represents a firm fixed price purchase of Trulicity 1.5 mg/0.5 ml pens valued at $1,744.44 through the Defense Logistics Agency (DLA). The award is non-competitive and competitively awarded, with performance scheduled for completion by December 12, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio supplying brand-name and generic medications, vaccines, and specialized medical supplies to the Defense Health Agency and other government healthcare systems. Trulicity, a diabetes management medication, represents one of numerous pharmaceutical products the contractor provides across multiple therapeutic domains. The delivery order structure and firm fixed pricing demonstrate the company's established capability to meet federal procurement requirements efficiently, leveraging its status as a prime contractor under the DLA's comprehensive pharmaceutical procurement vehicle supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/10/25 |